Evidence map›Paper›PMID 41438505›Full record

ReviewNew microbes and new infections2025

Insights into antibiotic resistance and prevalence of

Fatemeh Sameni, Ali Dadashi, Bahareh Hajikhani, Maedeh Pourali Eshkalak, Alex van Belkum, Ali Hashemi, Azadeh Alirezaei, Masoud Dadashi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Distribution and Antibiotic Resistance ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Global Comparative Genomics ofLife (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatemeh SameniInfectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali DadashiSchool of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bahareh HajikhaniDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maedeh Pourali EshkalakMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Alex van BelkumIndependent Microbiology Consultant, Jan van Goyenplein 31, 2231 MM Rijnsburg, the Netherlands.
Ali HashemiDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azadeh AlirezaeiDepartment of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Masoud DadashiDepartment of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infections caused by Objective: The main aim of this systematic review was to evaluate the prevalence of infections caused by this bacterium across different provinces of Iran. Additionally, the study assessed the resistance rates of commonly prescribed antibiotics to address existing gaps in therapeutic knowledge. Methods: A systematic literature review was conducted to identify relevant original research articles published in English between 2000 and 2024, using Google Scholar, Medline (via PubMed), Embase, and Web of Science. Following screening, all studies reporting antibiotic resistance in clinical isolates of Results: A total of 1415 clinical isolates were collected from 16 regions across Iran. Most isolates showed high susceptibility to ticarcillin/clavulanic acid and minocycline (98.5 % and 98.2 %, respectively). Among the genes associated with biofilm formation and antibiotic resistance, Conclusion: Given the low resistance rates to levofloxacin and minocycline, these antibiotics may be considered as potentially effective options for treating

Indexed as

Antibiotic resistanceBiofilmIranStenotrophomonas maltophilia

Identifiers

PMID41438505
PMCPMC12719980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.